You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,690,958


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,690,958
Title: Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life
Abstract:A unit dose chlorhexadine gluconate (CHG) applicator is disclosed wherein a unit dose of the CHG is contained in a hermetically sealed manually crushable glass ampule that has an internal volume not significantly greater than the unit dose volume of the CHG. The CHG in the ampule has an effective shelf life of at least 24 months. The glass ampule of the applicator is preferably protected by a flexible cover to protect the user's hand during manual crushing of the ampule to release the CHG therefrom. In one embodiment of the invention, a cylindrical glass ampule is housed within a tubular, flexible synthetic resin cover which has a porous applicator swab at one end thereof. Upon crushing of the glass ampule, the CHG released therefrom impregnates the swab allowing the user to spread the CHG across an area to be sanitized. In a second embodiment of the invention, a cylindrical glass ampule is received within a semi-cylindrical, open-sided body cover having a flange portion that mounts a sponge-like swab communicating with the interior of the body cover. Opposed integral wing-like gripping members on the ampule permit the user to crush the ampule by squeezing the members toward one another whereupon the CHG is released from the ampule and impregnates the sponge swab. The swab soaked with the CHG antiseptic may be rubbed across an area to be sanitized.
Inventor(s): McGrath; Patrick D. (Lenexa, KS)
Assignee: Medi-Flex Hospital Products, Inc. (Overland Park, KS)
Application Number:08/723,686
Patent Claim Types:
see list of patent claims
Delivery; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,690,958: A Detailed Analysis

Introduction

Patent 5,690,958, though not specifically detailed in the provided sources, can be analyzed using general principles and tools available for patent analysis. Here, we will outline how to approach such an analysis, focusing on the scope and claims of a patent, and how the current patent landscape, particularly updates and tools provided by the USPTO, can influence this understanding.

Patent Search and Retrieval

To begin analyzing a patent, it is crucial to retrieve the patent document itself. The USPTO provides several tools for searching and retrieving patent documents, including the Patent Public Search tool, which has replaced legacy search tools like PubEast and PubWest[4].

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention and what is protected. Here’s how to analyze them:

Claim Structure

Patent claims typically follow a specific structure, starting with an independent claim that broadly defines the invention, followed by dependent claims that narrow down the scope by adding additional limitations[4].

Claim Types

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to an independent claim and add additional limitations to narrow the scope.

Claim Analysis

When analyzing claims, it is essential to identify the key elements and how they interact. For example, in the context of AI-related inventions, the 2024 USPTO guidance update emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility[1].

Scope of the Invention

The scope of the invention is determined by the claims, but it is also influenced by the description and drawings provided in the patent specification.

Description and Drawings

The description and drawings provide context and details about the invention, helping to understand how the claimed elements function and interact. This is crucial for interpreting the claims and determining the scope of protection.

Real-World Applications

Highlighting real-world applications of the claimed method or system can bolster the argument for patent eligibility. For instance, the 2024 USPTO guidance update uses examples to show how claims involving AI technologies can meet eligibility criteria by demonstrating concrete technological improvements[1].

Patent Landscape and Recent Updates

The patent landscape is constantly evolving, with updates and new guidelines affecting how patents are evaluated.

2024 USPTO Guidance Update on AI Patents

The recent USPTO guidance update on AI patents is particularly relevant. It clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Examples and Case Law

The update includes new examples (Examples 47-49) that illustrate the application of subject matter eligibility analysis to AI-related claims. These examples help practitioners draft claims that are more likely to avoid section 101 rejections by showing how specific applications of AI technologies can meet the eligibility criteria[1].

Tools for Patent Analysis

Several tools and datasets are available to aid in patent analysis:

Patent Claims Research Dataset

The USPTO provides the Patent Claims Research Dataset, which contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can help in analyzing claim structures and trends[3].

Global Dossier and Common Citation Document

Tools like the Global Dossier and the Common Citation Document facilitate access to prior art and citation data, which are essential for understanding the patent landscape and the novelty of an invention[4].

Practical Applications and Benefits

Understanding the scope and claims of a patent is crucial for several reasons:

Patent Eligibility

Ensuring that the claimed invention integrates judicial exceptions into practical applications is key to overcoming section 101 rejections. This is particularly important for AI-related inventions, where the application of abstract ideas must be transformed into specific, practical applications[1].

Licensing and Enforcement

Accurate analysis of patent claims helps in licensing and enforcement. It ensures that the rights granted by the patent are clearly defined and enforceable.

Innovation and Development

For innovators, understanding the patent landscape and the scope of existing patents helps in developing new inventions that do not infringe on existing patents.

Key Takeaways

  • Claim Analysis: Focus on the structure and elements of the claims to understand the scope of the invention.
  • Real-World Applications: Highlighting practical applications of the claimed method or system is crucial for patent eligibility.
  • Recent Updates: The 2024 USPTO guidance update provides clarity on AI-related inventions and their patent eligibility.
  • Tools and Datasets: Utilize tools like the Patent Claims Research Dataset and Global Dossier to analyze claim trends and prior art.
  • Practical Applications: Ensure that the claimed invention integrates judicial exceptions into practical applications to meet patent eligibility criteria.

FAQs

Q: How do I retrieve a patent document from the USPTO?

A: You can use the Patent Public Search tool provided by the USPTO to search and retrieve patent documents[4].

Q: What is the importance of integrating judicial exceptions into practical applications in AI patents?

A: Integrating judicial exceptions into practical applications is essential for ensuring that AI-related inventions meet the criteria for patent eligibility, as it transforms abstract ideas into specific, practical applications[1].

Q: How does the 2024 USPTO guidance update affect AI-assisted inventions?

A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on the claimed invention itself rather than the method of invention development[1].

Q: What tools are available for analyzing patent claims and trends?

A: Tools like the Patent Claims Research Dataset and Global Dossier are available to aid in analyzing claim structures and trends, as well as accessing prior art and citation data[3][4].

Q: Why is understanding the scope of a patent important?

A: Understanding the scope of a patent is crucial for ensuring patent eligibility, licensing, enforcement, and developing new inventions that do not infringe on existing patents.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent Small Claims Court - ACUS
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,690,958

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,690,958

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 262323 ⤷  Subscribe
Australia 3664697 ⤷  Subscribe
Australia 713957 ⤷  Subscribe
Brazil 9712117 ⤷  Subscribe
Canada 2263158 ⤷  Subscribe
China 1092529 ⤷  Subscribe
China 1231602 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.